Abbott Laboratories (ABT)
Working capital turnover
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 43,843,000 | 43,109,000 | 42,344,000 | 41,950,000 | 41,217,000 | 40,725,000 | 40,326,000 | 40,109,000 | 39,959,000 | 40,226,000 | 41,505,000 | 43,653,000 | 45,030,000 | 45,548,000 | 44,514,000 | 43,075,000 | 42,308,000 | 40,233,000 | 37,338,000 | 34,608,000 |
| Total current assets | US$ in thousands | 24,839,000 | 24,468,000 | 23,153,000 | 23,656,000 | 23,802,000 | 23,119,000 | 22,376,000 | 22,670,000 | 22,664,000 | 23,505,000 | 25,224,000 | 25,224,000 | 24,845,000 | 24,956,000 | 23,429,000 | 24,239,000 | 23,492,000 | 22,627,000 | 21,817,000 | 20,441,000 |
| Total current liabilities | US$ in thousands | 14,582,000 | 13,439,000 | 13,004,000 | 14,157,000 | 14,902,000 | 13,760,000 | 14,021,000 | 13,841,000 | 13,042,000 | 14,350,000 | 15,489,000 | 15,489,000 | 13,365,000 | 12,392,000 | 12,647,000 | 13,105,000 | 12,867,000 | 12,614,000 | 12,462,000 | 11,907,000 |
| Working capital turnover | 4.27 | 3.91 | 4.17 | 4.42 | 4.63 | 4.35 | 4.83 | 4.54 | 4.15 | 4.39 | 4.26 | 4.48 | 3.92 | 3.63 | 4.13 | 3.87 | 3.98 | 4.02 | 3.99 | 4.06 |
September 30, 2025 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $43,843,000K ÷ ($24,839,000K – $14,582,000K)
= 4.27
Peer comparison
Sep 30, 2025
Company name
Symbol
Working capital turnover
Abbott Laboratories
ABT
4.27
CONMED Corporation
CNMD
3.88
Stryker Corporation
SYK
3.61
See also:
Abbott Laboratories Working Capital Turnover (Quarterly Data)